To include your compound in the COVID-19 Resource Center, submit it here.

Renova to begin Phase III of RT-100 in heart failure

Renova Therapeutics (San Diego, Calif.) said it will start this quarter the Phase III FLOURISH trial of gene therapy RT-100 (Ad5.hAC6) to

Read the full 222 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE